These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14293803)

  • 21. Pharmacologic reduction in tumor necrosis factor activity of pulmonary alveolar macrophages.
    Leeper-Woodford SK; Fisher BJ; Sugerman HJ; Fowler AA
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):169-75. PubMed ID: 8093999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [THE SOLVENT CAPACITY OF TWEEN 20, 60, 80 FOR SOME DRUGS DIFFICULT TO DISSOLVE IN WATER. 2].
    KUETTEL D
    Pharm Zentralhalle Dtschl; 1964; 103():10-6. PubMed ID: 14210093
    [No Abstract]   [Full Text] [Related]  

  • 23. Micellar solubilization of barbiturates. II. Solubilities of certain barbiturates in polyoxyethylene stearates of varying hydrophilic chain length.
    Gouda MW; Ismail AA; Motawi MM
    J Pharm Sci; 1970 Oct; 59(10):1402-5. PubMed ID: 5471942
    [No Abstract]   [Full Text] [Related]  

  • 24. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.
    Klueglich M; Ring A; Scheuerer S; Trommeshauser D; Schuijt C; Liepold B; Berndl G
    J Clin Pharmacol; 2005 Sep; 45(9):1055-61. PubMed ID: 16100300
    [No Abstract]   [Full Text] [Related]  

  • 25. [USE OF SPOT ANALYSIS FOR THE DETECTION OF 5-PHENYL-5-ETHYL-2- THIOBARBITURIC ACID (THIOPHENOBARBITAL) AND 5-PHENYL-5-ETHYLBARBITURIC ACID (PHENOBARBITAL) IN ADDITION TO 5-PHENYL-5-ETHYLHEXAHYDROPYRIMIDINE-4,6-DIONE (PRIMIDONE)].
    HAUG U; PANESCU I
    Pharmazie; 1963 May; 18():340-1. PubMed ID: 14056677
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
    Ulloque RA; Chweh AY; Swinyard EA
    J Pharmacol Exp Ther; 1986 May; 237(2):468-72. PubMed ID: 3009786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ACTION OF MEPROBAMATE-BARBITURATE COMBINATION ON EXPERIMENTAL SHAY GASTRIC ULCERS].
    LOSCALZO B; DIMEZZA F
    Gazz Int Med Chir; 1963 Sep; 67():1798-9. PubMed ID: 14090683
    [No Abstract]   [Full Text] [Related]  

  • 28. Column chromatographic analysis of barbiturates in their dosage forms. IV. Combinations with parabens.
    Barkan S; Doyle TD
    J Assoc Off Anal Chem; 1977 Sep; 60(5):1022-9. PubMed ID: 19414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cycloheptaamylose-barbiturate inclusion complexes: solubility and circular dichroism studies.
    Thakkar AL; Kuehn PB; Perrin JH; Wilham WL
    J Pharm Sci; 1972 Nov; 61(11):1841-3. PubMed ID: 4652667
    [No Abstract]   [Full Text] [Related]  

  • 30. EFFECT OF CHRONIC ADMINISTRATION AND WITHDRAWAL OF BARBITURATES UPON DRINKING IN THE RAT.
    SCHMIDT H; KLEINMAN KM
    Arch Int Pharmacodyn Ther; 1964 Sep; 151():142-9. PubMed ID: 14205407
    [No Abstract]   [Full Text] [Related]  

  • 31. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
    Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
    Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micellar solubilization of barbiturates. I. Solubilities of certain barbiturates in polysorbates of varying hydrophobic chain length.
    Ismail AA; Gouda MW; Motawi MM
    J Pharm Sci; 1970 Feb; 59(2):220-4. PubMed ID: 5411344
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug solubilization by complexation.
    Loftsson T
    Int J Pharm; 2017 Oct; 531(1):276-280. PubMed ID: 28842309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [THE USE OF KOLLIDON IN BARBITURATE ANESTHESIA FOR CESAREAN SECTION].
    ANDREUCCI S; MARTINI S
    Minerva Anestesiol; 1963 Oct; 29():453-7. PubMed ID: 14112399
    [No Abstract]   [Full Text] [Related]  

  • 35. [ON THE EXTRACORPOREAL HEMODIALYSIS OF BARBITURIC ACIDS].
    GOLDHAHN WE; OTTO P
    Arzneimittelforschung; 1963 Nov; 13():977-80. PubMed ID: 14210437
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissolution mechanisms of drug-polyvinylpyrrolidone coprecipitates in aqueous solution.
    Sekikawa H; Nakano M; Arita T
    Chem Pharm Bull (Tokyo); 1979 May; 27(5):1223-30. PubMed ID: 498375
    [No Abstract]   [Full Text] [Related]  

  • 37. N-Halo derivatives VI: Microbiological and chemical evaluations of 3-chloro-2-oxazolidinones.
    Kosugi M; Kaminski JJ; Selk SH; Pitman IH; Bodor N; Higuchi T
    J Pharm Sci; 1976 Dec; 65(12):1743-6. PubMed ID: 1032655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of gel chromatography for the separation of barbiturate mixtures].
    Popova VI; Kramarenko VF
    Farmatsiia; 1974; 23(4):51-2. PubMed ID: 4417207
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Furan derivatives of 3-amino-2-oxazolidinone].
    SWIRSKA A; MICHALSKI K
    Acta Pol Pharm; 1962; 19():459-60. PubMed ID: 13979736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.